首页> 外文期刊>Advances in Pharmacology and Pharmacy >A Novel Integrated (OF-HC-EPM) Approach to Study Anxiety Related Depressive Behavior in Mice Model: A Comparison of Neuro Standards
【24h】

A Novel Integrated (OF-HC-EPM) Approach to Study Anxiety Related Depressive Behavior in Mice Model: A Comparison of Neuro Standards

机译:研究小鼠模型中与焦虑相关的抑郁行为的新型综合(OF-HC-EPM)方法:神经标准的比较

获取原文
       

摘要

Open Field, Hole Cross and EPM are three widely acceptable experimental methods used to evaluate sedative-anxiolytic potential. The theories behind introducing these fields were to challenge the rodents to a novel environment. However, the behavioral changes caused by these environments often get influenced by rodent's identical neurologic conditions. The major challenges faced by the researchers are variations due to first administration against repeated administration, utilizing same rodent for another experiment but in different time or using different rodent for different experiments. Keeping the drawbacks in consideration, the present study undertook a newly modified (OF-HC-EPM) approach to integrate the experimental fields so as to utilize the same rodents with single oral administration for exposure to different fields which had allowed nullifying the risk of individual and time dependent variance. Anxiolytics, atypical antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants as well as the combined anxiolytics and antidepressants were administered to Swiss Albino Mice and their respective behavioral changes were observed. The new approach proved to be an essential tool for evaluating neuropharmacological potentials.
机译:开场,孔洞交叉和EPM是用于评估镇静抗焦虑潜力的三种广泛接受的实验方法。引入这些领域的理论是要向啮齿动物挑战一个新颖的环境。但是,由这些环境引起的行为改变通常会受到啮齿动物相同的神经系统状况的影响。研究人员面临的主要挑战是由于第一次给药与重复给药之间的差异,将相同的啮齿动物用于另一项实验,但在不同的时间,或将不同的啮齿动物用于不同的实验。考虑到这些弊端,本研究采用了一种新的改良(OF-HC-EPM)方法来整合实验场,以便将同一只啮齿动物与单次口服一起用于不同的领域,从而消除了个体的风险和时间相关的方差。向瑞士白化病小鼠服用抗焦虑药,非典型抗抑郁药,选择性5-羟色胺再摄取抑制剂,5-羟色胺-去甲肾上腺素再摄取抑制剂,三环类抗抑郁药以及抗焦虑药和抗抑郁药合用。新方法被证明是评估神经药理潜力的重要工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号